Article ID Journal Published Year Pages File Type
5702662 Urologic Oncology: Seminars and Original Investigations 2017 10 Pages PDF
Abstract
Changes in NLR levels could be predictive for prognosis in patients with mRCC treated with first-line and second-line targeted therapy. The addition of NLR significantly improves the predictive accuracy of the IMDC risk model in the first-line and subsequent second-line setting.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , , , , , , , , , , , , , ,